ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Integrating Vibrio natriegens for Photon Manipulation in Living Lighting Devices.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Photon manipulation with bacteria is an emerging field in photonics (lasers, bio-imaging, and cell-sensing) and optoelectronics (bacterial-hybrid light-emitting diodes (BaHLEDs) and photovoltaics). In BaHLEDs, living photon down-conversion filters based on the direct use of bacteria in optically desirable hydrophobic and/or waterless coatings have not been realized yet. Herein, we put forward a simple concept: the engineering of fluorescent Vibrio natriegens (V. natriegens) that enable easy-to-prepare, untreated bacteria-silicone filters for the first red-emitting BaHLEDs. More specifically, we have rationalized genetic and material engineering tools to optimize i) the protein production time with a 1.7-fold enhanced volumetric productivity compared to E. coli with the same spectroscopic quality for the fluorescent protein (FP) DsRed, ii) the straightforward fabrication of highly emissive and stable V. natriegens-silicones, and iii) device reproducibility and performance to reach competitive devices with stabilities ranging from a few days up to weeks depending on device working conditions and architectures. Overall, this work sets in bacterial photon down-conversion using V. natriegens directly as a viable and more straightforward concept toward further advances in living lighting applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.